Literature DB >> 27064362

Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.

Takahiro Tanahashi1, Nodoka Sekiguchi2, Kazuyuki Matsuda3, Yuka Takezawa3, Toshiro Ito4, Hikaru Kobayashi5, Naoaki Ichikawa5, Sayaka Nishina4, Noriko Senoo4, Hitoshi Sakai4, Hideyuki Nakazawa4, Fumihiro Ishida6.   

Abstract

Large granular lymphocyte leukemia (LGL-L) has been morphologically defined as a group of lymphoproliferative disorders, including T-cell large granular lymphocytic leukemia (T-LGL-L), chronic lymphoproliferative disorders of NK cells (CLPD-NK) and aggressive NK cell leukemia. We investigated the morphological features of LGL leukemic cells in 26 LGL-L patients in order to elucidate relationships with current classifications and molecular backgrounds. LGL-L cells were mostly indistinguishable from normal LGL. Patients with STAT3 SH2 domain mutations showed significantly smaller cells compared with patients without STAT3 mutations. Four patients with T-LGL-L showed smaller granular lymphocytes with a median diameter of less than 13μm, which were rarely seen in normal subjects. This small subtype of T-LGL-L was recognized among rather young patients and was associated with D661Y mutations in the STAT3 gene SH2 domain. In addition, all of them showed anemia including two cases with pure red cell aplasia. These results suggest the heterogeneity of T-LGL-L and a specific subtype with small variants of T-LGL-L.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxic T cell; Granular lymphocyte; LGL; Large granular lymphocyte leukemia; STAT3 mutation

Mesh:

Substances:

Year:  2016        PMID: 27064362     DOI: 10.1016/j.leukres.2016.04.001

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia.

Authors:  Takahiro Tanahashi; Nodoka Sekiguchi; Kazuyuki Matsuda; Akihiro Matsumoto; Toshiro Ito; Hideyuki Nakazawa; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2016-09-29       Impact factor: 2.490

Review 2.  Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.

Authors:  Kazuo Oshimi
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

3.  [Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer].

Authors:  Yuchen Bao; Yinmin Zhao; Bin Chen; Jie Luo; Qinfang Deng; Hui Sun; Boxiong Xie; Songwen Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-12-20

4.  Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia.

Authors:  Austin B Henslee; Timothy A Steele
Journal:  Biomark Res       Date:  2018-08-09

5.  Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.

Authors:  Kristine C Olson; Katharine B Moosic; Marieke K Jones; Paige M K Larkin; Thomas L Olson; Mariella F Toro; Todd E Fox; David J Feith; Thomas P Loughran
Journal:  Cancer Med       Date:  2020-07-25       Impact factor: 4.452

6.  STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features.

Authors:  Noemí Muñoz-García; María Jara-Acevedo; Carolina Caldas; Paloma Bárcena; Antonio López; Noemí Puig; Miguel Alcoceba; Paula Fernández; Neus Villamor; Juan A Flores-Montero; Karoll Gómez; María Angelina Lemes; Jose Carlos Hernández; Iván Álvarez-Twose; Jose Luis Guerra; Marcos González; Alberto Orfao; Julia Almeida
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.